NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM152277 Query DataSets for GSM152277
Status Public on Jan 08, 2007
Title Expression analysis of primary mouse megakaryocyte differentiation-MK6
Sample type RNA
 
Source name Mouse primary Megakaryocytes stage MK6
Organism Mus musculus
Characteristics mouse CD1 day 14.5 fetal liver cultured megakaryocytes collected at day 6
Extracted molecule total RNA
Extraction protocol Trizol reagents
Label biotin
Label protocol RNA is converted into cDNA using a T7 promoter-tailed oligo-dT primer in the synthesis of the first cDNA strand; second strand cDNA synthesis is then carried out.
The double-stranded cDNA is used as the template in an in vitro transcription (IVT) reaction catalyzed by T7 polymerase and containing biotinylated CTP and UTP in addition to the four unmodified ribonucleoside triphosphates.
The biotinylated complementary RNA (cRNA) is purified from the IVT reaction mixture using the RNeasy system (Qiagen). The cRNA is quantified spectrophotometrically and purity of the cRNA is also assessed by spectrophometric measurements. Those cRNA.s that fall outside of an acceptable range will not be carried forward in the analysis. Should this occur, investigators would be notified and asked to provide a new RNA sample
 
Hybridization protocol The purified cRNA is fragmented in order to facilitate the subsequent hybridization step. The cRNA is purified from the fragmentation reaction using phenol/chloroform extraction and ethanol precipitation.
The fragmented cRNA is added to a hybridization solution containing several biotinylated control oligonucleotides (for quality control), and hybridized to a microarray chip overnight at 45°C.
The chips are then transferred to a fluidics instrument that performs washes to remove cRNA that has not hybridized to its complementary oligonucleotide probe. The bound cRNA is then fluorescently labeled using phycoerythrin-conjugated streptavidin (SAPE); additional fluors are then added using biotinylated anti-streptavidin antibody and additional SAPE.
Scan protocol Each cRNA bound at its complementary oligonucleotide is excited using a confocal laser scanner, and the positions and intensities of the fluorescent emissions are captured. These measures provide the basis of subsequent biostatistical analysis.
Description none
Data processing Affymetrix MAS 5.0
 
Submission date Dec 21, 2006
Last update date Jan 08, 2007
Contact name Ramesh A Shivdasani
E-mail(s) ramesh_shivdasani@dfci.harvard.edu
Phone 617 632-5746
Fax 617 632-5417
URL http://research.dfci.harvard.edu/shivdasani
Organization name Dana-Farber Cancer Institute
Department Medical Oncology
Lab Shivdasani
Street address 44 Binney St.
City Boston
State/province MA
ZIP/Postal code 02115
Country USA
 
Platform ID GPL339
Series (1)
GSE6593 Expression analysis of primary mouse megakaryocyte differentiation

Data table header descriptions
ID_REF
VALUE signals calculated by affy MAS 5.0
ABS_CALL presence call
DETECTION P-VALUE statistical p-value for presence call

Data table
ID_REF VALUE ABS_CALL DETECTION P-VALUE
AFFX-BioB-5_at 165.144 P 0.00141043
AFFX-BioB-M_at 280.231 P 0.00010954
AFFX-BioB-3_at 169.446 P 4.42873e-05
AFFX-BioC-5_at 533.634 P 7.00668e-05
AFFX-BioC-3_at 340.243 P 4.42873e-05
AFFX-BioDn-5_at 396.533 P 5.16732e-05
AFFX-BioDn-3_at 2111.81 P 6.02111e-05
AFFX-CreX-5_at 4805.91 P 4.42873e-05
AFFX-CreX-3_at 7435.4 P 4.42873e-05
AFFX-DapX-5_at 13.46 A 0.165861
AFFX-DapX-M_at 14.5356 A 0.300606
AFFX-DapX-3_at 2.10509 A 0.976071
AFFX-LysX-5_at 7.46544 A 0.48511
AFFX-LysX-M_at 6.82115 A 0.712257
AFFX-LysX-3_at 2.57055 A 0.48511
AFFX-PheX-5_at 1.7579 A 0.953518
AFFX-PheX-M_at 2.9824 A 0.772364
AFFX-PheX-3_at 12.3646 A 0.51489
AFFX-ThrX-5_at 2.73859 A 0.891021
AFFX-ThrX-M_at 21.1098 A 0.425962

Total number of rows: 22690

Table truncated, full table size 690 Kbytes.




Supplementary file Size Download File type/resource
GSM152277.CEL.gz 3.4 Mb (ftp)(http) CEL

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap